Search results
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 6 days agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
How AI Is Revolutionizing Drug Development
The New York Times via Yahoo News· 7 days agoMONROVIA, Calif. — The laboratory at Terray Therapeutics is a symphony of miniaturized automation. Robots whir, shuttling tiny tubes of fluids to their...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 5 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
The New York Times via Yahoo News· 3 days agoAmericans are paying too much for prescription drugs. It is a common, long-standing complaint. And...
Pharma giant's data breach exposes patients' sensitive information
Fox News· 7 days agoU.S. pharmaceutical giant Cencora has been affected by a data breach. The company is notifying...
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 7 days agoRegeneron has released encouraging trial results for its multiple myeloma antibody, linvoseltamab....
Beyond BCMA-Directed CAR T-Cell Therapy
MedPage Today· 3 days agoAlthough survival rates for patients with multiple myeloma are improving, with a 5-year rate of about 60%, many patients relapse after treatment....
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
New York Times· 3 days agoPharmacy benefit managers are driving up drug costs for millions of people, employers and the...
Radiopharma specialist Telix pulls last-minute plug on $232m IPO
Pharmaceutical Technology via Yahoo Finance· 7 days agoIn the latest development in the ever-changing biotech IPO landscape, Telix Pharmaceuticals has...
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
BioPharma Dive via Yahoo Finance· 3 days agoA medicine Jazz acquired in 2019 missed the goal of a Phase 2 study. Elsewhere, Vanda rejected two...
